Page 6 - Remunity Pump News Today

Cordatus Wealth Management LLC bought a new stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during the 2nd quarter, HoldingsChannel reports. The institutional investor bought 1,075 shares of the biotechnology company’s stock, valued at approximately $237,000. Other large investors have also added to or reduced their stakes in the company. Machina Capital […]

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating and eight have assigned a buy rating to the company. The average 1-year […]

New England Research & Management Inc. grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 12.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,280 shares of the biotechnology company’s stock after buying an additional […]

Financial Gravity Asset Management Inc. cut its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 19.4% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 224 shares of the biotechnology company’s stock after selling 54 shares during the period. Financial Gravity Asset Management Inc.’s […]

Farallon Capital Management LLC boosted its holdings in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 664,767 shares of the biotechnology company’s stock after acquiring an additional 8,894 shares during the period. Farallon […]

Axiom Investors LLC DE lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 23.4% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,423 shares of the biotechnology company’s stock after selling 1,043 shares during the period. Axiom Investors LLC DE’s holdings […]

Aviva PLC boosted its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 677.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,015 shares of the biotechnology company’s stock after purchasing an additional 79,312 shares during the quarter. Aviva […]

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ten ratings firms that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating and eight have issued a buy rating on the company. The average 1-year […]

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. acquired a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 16,010 shares of the biotechnology company’s stock, valued at approximately $3,586,000. Several other hedge funds […]

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) EVP Paul A. Mahon sold 6,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $236.25, for a total transaction of $1,417,500.00. Following the completion of the sale, the executive vice president now directly owns 36,599 […]